Winton Group LTD Neogenomics Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Winton Group LTD holds 25,490 shares of NEO stock, worth $469,780. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,490

Holding current value

$469,780

% of portfolio

0.03%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $341,566 - $451,937	25,490 New	25,490 $375,000
Q3 2023 Nov 13, 2023	BUY	$12.15 - $17.85 $131,414 - $193,065	10,816 New	10,816 $133,000
Q3 2019 Nov 08, 2019	SELL	$19.12 - $26.24 $289,993 - $397,982	-15,167 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$19.57 - $24.1 $293,256 - $361,138	-14,985 Reduced 49.7%	15,167 $333,000
Q1 2019 May 13, 2019	BUY	$12.14 - $20.46 $10,658 - $17,963	878 Added 3.0%	30,152 $617,000
Q4 2018 Feb 05, 2019	BUY	$11.24 - $18.5 $42,082 - $69,264	3,744 Added 14.67%	29,274 $369,000
Q3 2018 Nov 02, 2018	BUY	$12.5 - $15.38 $60,825 - $74,839	4,866 Added 23.55%	25,530 $0
Q2 2018 Aug 20, 2018	SELL	$7.99 - $14.05 $165,968 - $291,846	-20,772 Reduced 50.13%	20,664 $0
Q1 2018 May 21, 2018	BUY	$7.23 - $8.76 $299,582 - $362,979	41,436 New	41,436 $0

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$363 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$259 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$127 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$122 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$121 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.32B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account